Need help? Text us and our team of experts will reply in minutes +1 949-694-6162
Need help? Text us and our team of experts will reply in minutes +1 949-694-6162
106612-94-6
Price range: $84.99 through $144.99
All products are intended solely for laboratory research and are not for human or animal consumption. By purchasing, the buyer agrees to use these products in compliance with all applicable laws.
Third-party tested for 99% purity, ID, quantity.
Third-party tested for endotoxins
Glucagon-like peptide-1 (GLP-1) is an endogenous 31-amino-acid incretin peptide hormone secreted by intestinal L-cells in response to food intake. It plays a critical role in glucose homeostasis and appetite regulation. In preclinical and laboratory settings, GLP-1 is studied for its ability to stimulate glucose-dependent insulin secretion, suppress glucagon release, delay gastric emptying, and promote satiety via central nervous system receptor activation.
GLP-1 was discovered in the 1980s following cloning of the preproglucagon gene, with Svetana Mojsov identifying GLP-1 (7-37) as the active insulinotropic peptide in 1986. Further physiological studies established its incretin role in humans. Due to its rapid degradation by dipeptidyl peptidase-4 (DPP-4), subsequent research focused on developing stable, long-acting synthetic receptor agonists (such as liraglutide and semaglutide) to study sustained endocrine and metabolic pathways.
GLP-1 has been rigorously evaluated in laboratory models of glycemic regulation, satiety control, and cellular cytoprotection. Studies highlight its role in activating adenylate cyclase to increase cyclic AMP (cAMP) levels, stimulating insulin release exclusively in the presence of elevated glucose, and promoting beta-cell viability. Additional research indicates potential neuroprotective, anti-inflammatory, and cardiovascular protective signaling cascades in experimental models.
Key Areas of Research:
Endocrine: Glucose-dependent insulin upregulation, beta-cell signaling, glucagon pathway inhibition
Satiety: Central receptor binding, appetite regulation, gastric emptying delay kinetics
Cardiovascular: Endothelial protection, blood flow dynamics, anti-inflammatory receptor signaling
Together, these investigations reveal GLP-1’s central role in homeostatic endocrine feedback loops. By safely balancing glucose levels and suppressing intake signals without inducing hypoglycemic states, GLP-1 serves as a fundamental platform for research into incretin pharmacology, pancreatic health, and metabolic pathways.
Mojsov S. et al. (1986). Preproglucagon gene expression in pancreas and intestine at the level of posttranslational processing. Journal of Biological Chemistry, 261(25):11880-11889. URL: https://pubmed.ncbi.nlm.nih.gov/3528148/
Kreymann B. et al. (1987). Glucagon-like peptide-1 7-36: a physiological incretin in man. Lancet, 2(8571):1300-1304. URL: https://pubmed.ncbi.nlm.nih.gov/2890903/
STEP 1
Precision Lyophilization
Manufactured in a controlled U.S. facility under strict compounding standards.
STEP 2
Verified Purity
Every batch third-party tested with HPLC and mass spectrometry.
STEP 3
Same-Day Fulfillment
Orders dispatched same-day from our
U.S. facility.
Everything you need to know about our products and processes.
